Who are we?


The GeoLynch study is conducted by Wageningen University in cooperation with the Dutch Foundation for Detection of Hereditary Tumors (StOET) in Leiden, and the Gastroenterology and Hepatology departments of the Radboud University Medical Center in Nijmegen and the University Medical Center in Groningen.

The daily work is conducted by Wageningen University:

Other persons that are involved include:

  • Prof dr Hans Vasen, Medical Director of the Dutch Foundation for Detection of Hereditary Tumors (StOET)

  • Dr Fokko Nagengast, previously Gastroenterologist at the Radboud University Medical Center, currently Gastroenterologist at Slingeland Ziekenhuis, Doetinchem

  • Dr Jan Kleibeuker, head of the department of Gastroenterology and Hepatology at the University Medical Center Groningen